Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Ibuprofen for Pain in Pediatric Vital Pulp Therapy
NCT07114198Phase 1Completed
- Sponsor
- Inonu University
- Start
- Aug 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of ibuprofen in reversible pulpitis (2 arms), sponsored by Inonu University. Primary endpoint: Change in Pain Intensity From Baseline to Immediately During the Procedure at Day 0. Started Aug 2025; status: completed.
02
Drugs
ibuprofen
03
Conditions
reversible pulpitis
Beyond the preview
Go deeper on NCT07114198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07114198.